By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950



Company News
Bellicum (BLCM) Announces Late-Breaking Presentation Of Dual-Switch CAR-T / TCR Technology At AACR 4/4/2017 11:00:22 AM
Bellicum (BLCM) Announces Closing Of Public Offering 3/30/2017 11:21:17 AM
Bellicum (BLCM) Announces Pricing Of Public Offering Of Common Stock 3/24/2017 8:18:01 AM
Bellicum (BLCM) Announces Proposed Public Offering Of Common Stock 3/23/2017 11:53:54 AM
Bellicum (BLCM) Provides Operational Update And Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2016 3/14/2017 11:04:32 AM
Bellicum (BLCM) To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call And Webcast On March 13, 2017 3/6/2017 10:52:08 AM
Bellicum (BLCM) Presents Updated Clinical Results At 2017 BMT Tandem Meetings On BPX-501 In Orphan Inherited Blood Disorders And Hematologic Cancers 2/23/2017 12:32:46 PM
Bellicum (BLCM) Announces Initiation Of Patient Dosing With Controllable CAR T-Cell Product Candidate 2/21/2017 10:52:08 AM
Genentech (RHHBY)'s Oncology Boss Jumps Ship to Helm Bellicum (BLCM) 1/31/2017 5:48:20 AM
Bellicum (BLCM) Announces GoCAR-T and GoTCR Preclinical Presentations at the American Society of Hematology 2016 Annual Meeting 12/6/2016 11:54:42 AM